These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2952500)

  • 1. Disk diffusion and disk elution tests with A-56268 and erythromycin.
    Barry AL; Jones RN; Thornsberry C
    Eur J Clin Microbiol; 1987 Feb; 6(1):109-11. PubMed ID: 2952500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve].
    Soussy CJ; Le Van Thoi J; Cluzel M; Derlot E; Kitzis MD
    Pathol Biol (Paris); 1990 May; 38(5):401-6. PubMed ID: 2142274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
    Barry AL; Thornsberry C; Gavan TL
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression analysis, proposed interpretative zone size standards, and quality control guidelines for a new macrolide antimicrobial agent, A-56268 (TE-031).
    Hanson CW; Bailer R; Gade E; Rode RA; Fernandes PB
    J Clin Microbiol; 1987 Jun; 25(6):1079-82. PubMed ID: 2954995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test.
    Barry AL; Fernandes PB; Jorgensen JH; Thornsberry C; Hardy DJ; Jones RN
    J Clin Microbiol; 1988 Nov; 26(11):2415-20. PubMed ID: 2976773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disk diffusion sensitivity testing and antibacterial activity of azithromycin.
    Davila D; Tambić T; Djokić S; Kolacny-Babić L
    Arzneimittelforschung; 1992 Feb; 42(2):156-9. PubMed ID: 1319164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Feb; 38(2):211-6. PubMed ID: 8192445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the 10-micrograms clindamycin disk for susceptibility testing of anaerobes by the aerobically incubated thioglycolate broth disk method.
    Toohey KL; Kurzynski TA; Schell RF; Birk RJ; Zabransky RJ
    J Clin Microbiol; 1986 Mar; 23(3):619-21. PubMed ID: 3958150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters.
    Barry AL; Pfaller MA; Fuchs PC
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():27-37. PubMed ID: 8478310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broth-disk elution tests to predict the susceptibility of anaerobic bacteria to the ampicillin-sulbactam combination.
    Jones RN
    Diagn Microbiol Infect Dis; 1990; 13(4):353-5. PubMed ID: 2076598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
    Fuchs PC; Barry AL; Jones RN; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):185-92. PubMed ID: 3471371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of susceptibility of anaerobic bacteria to cefotetan and cefoxitin by the thioglycolate disk elution method.
    Barry AL; Packer RR
    J Clin Microbiol; 1984 Nov; 20(5):912-6. PubMed ID: 6595259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerobically incubated thioglycolate broth disk method for antibiotic susceptibility testing of anaerobes.
    Kurzynski TA; Yrios JW; Helstad AG; Field CR
    Antimicrob Agents Chemother; 1976 Oct; 10(4):727-32. PubMed ID: 984807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the test medium on azithromycin and erythromycin regression statistics.
    Barry AL; Fuchs PC
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):846-9. PubMed ID: 1662629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease.
    Shryock TR; White DW; Staples JM; Werner CS
    J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-vitro and disc susceptibility testing of clarithromycin and its 14-hydroxy metabolite.
    Logan MN; Ashby JP; Andrews JM; Wise R
    J Antimicrob Chemother; 1991 Feb; 27(2):161-70. PubMed ID: 1829073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
    Jones RN; Barry AL; Fuchs PC; Thornsberry C
    J Clin Microbiol; 1986 Aug; 24(2):233-9. PubMed ID: 3091634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefixime disk susceptibility test criteria.
    Fuchs PC; Barry AL; Jones RN
    J Clin Microbiol; 1986 Oct; 24(4):647-9. PubMed ID: 3771755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori.
    Grignon B; Tankovic J; Mégraud F; Glupczynski Y; Husson MO; Conroy MC; Emond JP; Loulergue J; Raymond J; Fauchère JL
    Microb Drug Resist; 2002; 8(1):61-6. PubMed ID: 12002651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.